Cite
Meyer MAS, Wiberg S, Grand J, et al. Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial. Circulation. 2021;143(19):1841-1851doi: 10.1161/CIRCULATIONAHA.120.053318.
Meyer, M. A. S., Wiberg, S., Grand, J., Meyer, A. S. P., Obling, L. E. R., Frydland, M., Thomsen, J. H., Josiassen, J., Møller, J. E., Kjaergaard, J., & Hassager, C. (2021). Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial. Circulation, 143(19), 1841-1851. https://doi.org/10.1161/CIRCULATIONAHA.120.053318
Meyer, Martin Abild Stengaard, et al. "Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial." Circulation vol. 143,19 (2021): 1841-1851. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.053318
Meyer MAS, Wiberg S, Grand J, Meyer ASP, Obling LER, Frydland M, Thomsen JH, Josiassen J, Møller JE, Kjaergaard J, Hassager C. Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial. Circulation. 2021 May 11;143(19):1841-1851. doi: 10.1161/CIRCULATIONAHA.120.053318. Epub 2021 Mar 22. PMID: 33745292; PMCID: PMC8104015.
Copy
Download .nbib